TScan Therapeutics (TCRX) Stock Highlights

4.12 | -2.14%

2024-11-21 05:03:37

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The companys lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Statistics

Range Today

4.03 4.23

Volume Today 165.5K

Range 1 Year

3.73 9.69

Volume 1 Year 59.97M

Range 3 Year

1.45 9.69

Volume 3 Year 188.38M

Range 10 Year

1.45 14.71

Volume 10 Year 197.04M

Highlights

Market Capitalization 314.67M (small)

Floating Shares 25.68M

Current Price 4.12

Price To Earnings -9.51

Price To Revenue 8.16

Price To Book 1.2

Earnings Per Share -0.63

Payout Ratio 0%

Performance

Latest -2.14%

1 Month -23.28%

3 Months -31.9%

6 Months -54.32%

1 Year -21.52%

3 Years -53.55%

5 Years -65.67%

10 Years -65.67%

Benchmarks

Market Capitalization

199 / 368

Gross Profits

193 / 278

Total Revenue

166 / 300

Total Rank

44 / 368

Free Cashflow

185 / 352

Performance 5 years

194 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.